Ajanta De, MD
Cardiovascular Disease (Cardiology) · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 6 carriers
- Offices
- 2
Offices
2 locations · Golden State Heart and Vascular Associates · Community Hospital of the Monterey Peninsula
Hospitals listed: 059175 · Community Hospital of the Monterey Peninsula · El Camino Health · Good Samaritan Hospital · Salinas Valley Health Medical Center · Watsonville Community Hospital. That is not proof they admit you there this week.
Plans that list them
28 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. De’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C55862 · Current
Licensed to practise in California · since 2013 · expires 2026-12-31 · Northeastern Ohio Universities College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
- Watsonville Community HospitalWatsonville, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Watsonville Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 194 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.6 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.7 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 604 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 1,963 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,942 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.66) · 232 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.24 (0.54 to 3.95) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.09 (0.81 to 9.36) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.35) · 1,464 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 82 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.4 · 221 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 182 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.2) · 311 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 46 cases | No different | Jan 2024 – Dec 2024 |
What patients said (264 patients answered, 12% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$1,838,610
Medicare paid this office $1,838,610 for 2,613 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of plaque and insertion of stents in arteries of leg | 23 | $280,002 | $9,032 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 83 | $225,260 | $1,382 |
| Removal of plaque in arteries of leg | 17 | $153,911 | $6,692 |
| Balloon dilation of artery of leg, initial vessel | 36 | $145,552 | $2,426 |
| Insertion of stent in arteries of leg | 16 | $108,874 | $5,730 |
See all 61 services
| Removal of plaque and insertion of stents in arteries of leg | 23 | $280,002 | $9,032 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 83 | $225,260 | $1,382 |
| Removal of plaque in arteries of leg | 17 | $153,911 | $6,692 |
| Balloon dilation of artery of leg, initial vessel | 36 | $145,552 | $2,426 |
| Insertion of stent in arteries of leg | 16 | $108,874 | $5,730 |
| Return visit (30+ min) | 396 | $72,644 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 350 | $61,707 | $153 |
| Short return visit (20+ min) | 477 | $61,591 | $69 |
| Ultrasound of leg arteries or artery grafts | 209 | $61,514 | $196 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 252 | $46,579 | $139 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 117 | $43,094 | $365 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 242 | $38,754 | $121 |
| Ultrasound of both sides of head and neck blood flow | 163 | $27,068 | $154 |
| Balloon dilation of artery of leg | 14 | $23,114 | $1,651 |
| Short return visit (20+ min) | 124 | $21,969 | $47 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 117 | $20,712 | $95 |
| New patient visit (45+ min) | 175 | $20,114 | $115 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 17 | $19,655 | $855 |
| Removal of skin and tissue, 20.0 sq cm or less | 106 | $17,297 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 238 | $13,335 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $12,405 | $91 |
| Review by radiologist of arm or leg artery image | 65 | $11,743 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $11,145 | $133 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,362 | $10,882 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 190 | $10,480 | $51 |
| Balloon dilation of artery of leg, each additional vessel | 14 | $10,427 | $695 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $9,825 | $409 |
| Ultrasound of heart with probe in esophagus, with report | 67 | $9,185 | $82 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 53 | $8,705 | $161 |
| Short return visit | 123 | $6,857 | $43 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 26 | $6,047 | $233 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 82 | $5,735 | $41 |
| Management of oxygen chamber therapy | 12 | $4,965 | $76 |
| Repair of left upper heart chamber with implant with review by radiologist | 11 | $4,859 | $442 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,005 | $334 |
| Ultrasonic guidance for blood vessel access | 66 | $3,565 | $30 |
| New patient visit (30+ min) | 57 | $3,338 | $59 |
| Ultrasound study of arm and leg arteries | 49 | $2,904 | $56 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,576 | $215 |
| Long return visit (40+ min) | 16 | $2,531 | $149 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 31 | $2,025 | $45 |
| Ultrasound of heart, follow-up | 84 | $1,943 | $20 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 105 | $1,746 | $17 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 64 | $1,655 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 148 | $1,492 | $9 |
| Review by radiologist of both arms or legs arteries image | 11 | $1,401 | $127 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $1,139 | $16 |
| Ultrasound of both sides of head and neck blood flow | 41 | $1,122 | $27 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,099 | $69 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 15 | $1,024 | $68 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $930 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68 | $921 | $11 |
| Hospital discharge day management, 30 minutes or less | 12 | $792 | $66 |
| Ultrasonic guidance for blood vessel access | 50 | $529 | $10 |
| Ultrasound of leg arteries or artery grafts | 14 | $422 | $30 |
| Injection, regadenoson, 0.1 mg | 52 | $356 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $241 | $17 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $205 | $16 |
| Injection, aminophyllin, up to 250 mg | 23 | $185 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $158 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $114 | $9 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 34 | More than 69% of doctors who do this |
| Leg revascularization (restoring blood flow) | 92 | More than 97% of doctors who do this |
| Pacemaker insertion or repair | 14 | More than 65% of doctors who do this |
| Removal of tissue | 459 | More than 96% of doctors who do this |
| Varicose vein removal | 106 | More than 85% of doctors who do this |
Who their Medicare patients are
2,613 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 26% · Women 51% · Also on Medicaid 22% · Health risk score 1.90. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Atrial fibrillation 39% · Diabetes 37% · Heart failure 36% · Chronic kidney disease 34% · Depression 26% · COPD 23% · Cancer 19% · Stroke 19% · Dementia 17%.
The office billed $5,906,985, Medicare allowed $2,391,059 and paid $1,838,610; for 9,418 services of 118 kinds; $541 of it was for drugs given in the office and $1,838,069 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,613 | 9,418 | 78 | 1.90 | $5,906,985 | $1,838,610 |
| 2023 | 2,611 | 8,788 | 78 | 1.84 | $5,642,131 | $1,726,389 |
| 2022 | 2,776 | 8,667 | 78 | 1.78 | $3,879,377 | $1,047,028 |
| 2021 | 2,196 | 7,347 | 77 | 1.73 | $4,810,968 | $896,309 |
| 2020 | 2,022 | 5,951 | 78 | 1.91 | $4,366,474 | $667,300 |
| 2019 | 2,103 | 4,978 | 78 | 1.80 | $3,287,034 | $463,000 |
| 2018 | 1,283 | 4,357 | 79 | 1.89 | $3,262,498 | $452,266 |
| 2017 | 1,295 | 4,246 | 78 | 1.91 | $2,777,598 | $466,531 |
| 2016 | 1,154 | 4,395 | 80 | 1.82 | $3,972,099 | $510,936 |
| 2015 | 510 | 2,294 | 80 | 1.82 | $1,727,093 | $222,878 |
| 2013 | 655 | 1,340 | 77 | 1.99 | $319,018 | $76,956 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 57 services
| Removal of plaque and insertion of stents in arteries of leg | 16 | $233,082 | $11,099 |
| Insertion of stent in arteries of leg | 27 | $228,119 | $7,129 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 59 | $143,665 | $1,545 |
| Balloon dilation of artery of leg, initial vessel | 29 | $96,504 | $2,474 |
| Insertion of stent in artery of leg, initial vessel | 11 | $90,707 | $6,977 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 319 | $64,553 | $174 |
| Return visit (30+ min) | 338 | $61,642 | $111 |
| Ultrasound of leg arteries or artery grafts | 172 | $52,972 | $221 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 111 | $47,640 | $425 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 228 | $43,115 | $137 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 200 | $41,932 | $158 |
| Short return visit (20+ min) | 273 | $31,550 | $79 |
| Short return visit (20+ min) | 126 | $30,712 | $54 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 18 | $29,626 | $956 |
| Ultrasound of both sides of head and neck blood flow | 155 | $28,254 | $169 |
| Removal of skin and tissue, 20.0 sq cm or less | 113 | $24,155 | $49 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 38 | $21,966 | $414 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $17,851 | $145 |
| New patient visit (45+ min) | 124 | $16,140 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $15,359 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $14,275 | $57 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 79 | $13,913 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,444 | $12,086 | $7 |
| Injection, regadenoson, 0.1 mg | 99 | $11,431 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 61 | $10,586 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 176 | $10,373 | $55 |
| Balloon dilation of artery of leg, each additional vessel | 12 | $9,078 | $756 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 37 | $8,905 | $241 |
| Ultrasound of heart with probe in esophagus, with report | 50 | $7,214 | $89 |
| Ultrasound study of arm and leg arteries | 80 | $5,232 | $59 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,229 | $373 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 70 | $4,857 | $46 |
| Management of oxygen chamber therapy | 13 | $4,750 | $86 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 23 | $4,265 | $63 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 16 | $3,695 | $231 |
| Short return visit | 58 | $3,386 | $50 |
| Ultrasonic guidance for blood vessel access | 58 | $3,360 | $36 |
| New patient visit (30+ min) | 51 | $3,238 | $63 |
| Review by radiologist of arm or leg artery image | 16 | $2,789 | $133 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $2,039 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 27 | $1,832 | $57 |
| New patient visit (30+ min) | 19 | $1,830 | $96 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 66 | $1,794 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 148 | $1,786 | $10 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 91 | $1,642 | $18 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $1,604 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 35 | $1,315 | $24 |
| Ultrasound of heart, follow-up | 59 | $1,264 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,203 | $26 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 16 | $1,176 | $74 |
| External shock to heart to regulate heart beat | 12 | $1,110 | $92 |
| Ultrasonic guidance for blood vessel access | 56 | $786 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 53 | $664 | $12 |
| Ultrasound of both sides of head and neck blood flow | 21 | $641 | $31 |
| Ultrasound of leg arteries or artery grafts | 19 | $594 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $588 | $18 |
| Blood test, clotting time | 12 | $189 | $4 |
2022: 53 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 42 | $108,990 | $1,603 |
| Return visit (30+ min) | 382 | $91,383 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $56,092 | $185 |
| Short return visit (20+ min) | 394 | $55,584 | $78 |
| Ultrasound of leg arteries or artery grafts | 117 | $36,629 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 175 | $34,242 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 143 | $32,079 | $87 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 172 | $31,964 | $144 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 114 | $24,189 | $163 |
| Ultrasound of both sides of head and neck blood flow | 120 | $22,537 | $180 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 41 | $22,284 | $455 |
| Short return visit (20+ min) | 98 | $21,768 | $55 |
| Removal of skin and tissue, 20.0 sq cm or less | 95 | $17,254 | $49 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 86 | $17,113 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $16,560 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,732 | $14,981 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $14,431 | $451 |
| New patient visit (45+ min) | 94 | $12,494 | $133 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $9,327 | $345 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 51 | $8,545 | $110 |
| Ultrasound study of arm and leg arteries | 100 | $7,625 | $61 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 25 | $6,237 | $249 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 81 | $4,965 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 48 | $3,602 | $56 |
| Long return visit (40+ min) | 21 | $3,572 | $149 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $3,540 | $93 |
| Injection, regadenoson, 0.1 mg | 33 | $3,517 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $3,335 | $208 |
| New patient visit (30+ min) | 46 | $3,017 | $66 |
| Short return visit | 43 | $2,464 | $48 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 80 | $2,328 | $28 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 28 | $2,264 | $78 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 170 | $2,152 | $10 |
| Hospital discharge day management, 30 minutes or less | 33 | $2,138 | $63 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 105 | $1,887 | $18 |
| New patient visit (60+ min) | 11 | $1,875 | $170 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $1,587 | $50 |
| External shock to heart to regulate heart beat | 13 | $1,524 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 78 | $1,221 | $12 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 13 | $1,024 | $79 |
| Ultrasound of both sides of head and neck blood flow | 32 | $924 | $29 |
| Ultrasonic guidance for blood vessel access | 69 | $852 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $845 | $50 |
| Ultrasonic guidance for blood vessel access | 18 | $703 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 24 | $643 | $24 |
| Ultrasound of leg arteries or artery grafts | 17 | $555 | $33 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $533 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $407 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 13 | $353 | $11 |
| Ultrasound of heart, follow-up | 16 | $346 | $20 |
| Ultrasound of one leg arteries or artery grafts | 14 | $316 | $20 |
| Blood test, clotting time | 11 | $267 | $4 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $167 | $11 |
2021: 52 services
| Return visit (30+ min) | 373 | $108,341 | $114 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 25 | $95,679 | $1,914 |
| Short return visit (20+ min) | 286 | $36,512 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 139 | $29,120 | $176 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $25,409 | $208 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $25,151 | $92 |
| Ultrasound of leg arteries or artery grafts | 74 | $23,197 | $258 |
| Ultrasound of both sides of head and neck blood flow | 107 | $19,963 | $183 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 106 | $19,879 | $159 |
| Short return visit (20+ min) | 93 | $18,768 | $58 |
| Removal of skin and tissue, 20.0 sq cm or less | 91 | $15,208 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 225 | $14,800 | $61 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $14,246 | $475 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 66 | $13,916 | $188 |
| Long return visit (40+ min) | 62 | $12,594 | $161 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,149 | $9,609 | $7 |
| New patient visit (45+ min) | 62 | $9,258 | $149 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $7,428 | $190 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 27 | $7,098 | $263 |
| Insertion of stent in arteries of leg | 14 | $5,394 | $360 |
| Ultrasound study of arm and leg arteries | 63 | $5,057 | $68 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 38 | $4,941 | $112 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $3,402 | $243 |
| New patient visit (30+ min) | 37 | $2,595 | $70 |
| Programming of dual lead pacemaker system | 34 | $2,499 | $60 |
| New patient visit (60+ min) | 13 | $2,341 | $180 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 16 | $2,329 | $137 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $2,306 | $96 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 74 | $2,091 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 30 | $1,996 | $67 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 99 | $1,817 | $18 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,750 | $62 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 20 | $1,705 | $81 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $1,552 | $55 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 24 | $1,491 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 110 | $1,373 | $11 |
| External shock to heart to regulate heart beat | 12 | $1,270 | $98 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 55 | $1,224 | $19 |
| Review by radiologist of arm or leg artery image | 11 | $1,101 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68 | $1,014 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 22 | $906 | $12 |
| Ultrasonic guidance for blood vessel access | 18 | $868 | $38 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $827 | $55 |
| Ultrasound of both sides of head and neck blood flow | 26 | $795 | $31 |
| Short return visit | 14 | $780 | $52 |
| Ultrasonic guidance for blood vessel access | 47 | $657 | $12 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 26 | $617 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 26 | $436 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $402 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $212 | $13 |
| Blood test, clotting time | 15 | $210 | $4 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12 | $84 | $0 |
2020: 41 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 32 | $101,236 | $2,025 |
| Return visit (30+ min) | 354 | $95,695 | $98 |
| Long return visit (40+ min) | 166 | $37,208 | $132 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $20,134 | $479 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $18,467 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $15,263 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $13,194 | $64 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 49 | $10,344 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,150 | $9,743 | $7 |
| Ultrasound of both sides of head and neck blood flow | 46 | $9,211 | $200 |
| Insertion of stent in arteries of leg | 17 | $7,068 | $393 |
| Ultrasound of leg arteries or artery grafts | 22 | $6,022 | $274 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $5,977 | $187 |
| Short return visit (20+ min) | 73 | $5,337 | $65 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,302 | $379 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $5,277 | $310 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $4,997 | $178 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 15 | $4,485 | $299 |
| New patient visit (45+ min) | 32 | $4,382 | $137 |
| New patient visit (60+ min) | 22 | $3,819 | $174 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 29 | $3,022 | $84 |
| Programming of dual lead pacemaker system | 39 | $2,353 | $39 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $1,987 | $166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 102 | $1,935 | $17 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 63 | $1,812 | $29 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 109 | $1,423 | $11 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $1,415 | $109 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 71 | $1,353 | $18 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $1,326 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 41 | $1,287 | $28 |
| Ultrasound study of arm and leg arteries | 17 | $1,278 | $71 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 39 | $1,090 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $1,074 | $54 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,050 | $66 |
| Ultrasound of both sides of head and neck blood flow | 29 | $995 | $34 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 13 | $830 | $12 |
| Ultrasonic guidance for blood vessel access | 13 | $737 | $37 |
| Ultrasonic guidance for blood vessel access | 39 | $650 | $13 |
| Blood test, clotting time | 16 | $225 | $4 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $182 | $13 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11 | $99 | $0 |
2019: 41 services
| Return visit (30+ min) | 244 | $43,262 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $24,667 | $93 |
| Long return visit (40+ min) | 111 | $23,223 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $22,366 | $179 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 38 | $22,185 | $493 |
| Repair of mitral valve through the skin, initial prosthesis | 11 | $15,964 | $1,451 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 218 | $15,170 | $63 |
| Ultrasound of leg arteries or artery grafts | 44 | $11,983 | $266 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 56 | $11,524 | $206 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 55 | $11,263 | $201 |
| Replacement of aortic valve through the skin and femoral artery | 14 | $10,167 | $726 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,204 | $9,852 | $7 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $7,986 | $399 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 25 | $7,557 | $302 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 24 | $7,353 | $294 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 37 | $6,067 | $160 |
| New patient visit (45+ min) | 32 | $4,780 | $149 |
| Ultrasound of both sides of head and neck blood flow | 28 | $4,661 | $166 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 26 | $4,493 | $173 |
| Repair of mitral valve through the skin, additional prosthesis | 11 | $4,076 | $371 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 15 | $4,034 | $269 |
| Programming of dual lead pacemaker system | 47 | $3,972 | $61 |
| Short return visit (20+ min) | 49 | $3,794 | $63 |
| New patient visit (60+ min) | 17 | $3,113 | $183 |
| Ultrasound study of arm and leg arteries | 42 | $2,968 | $71 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,752 | $98 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 27 | $2,428 | $84 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $2,087 | $116 |
| Ultrasound of both sides of head and neck blood flow | 51 | $1,662 | $33 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 126 | $1,558 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 90 | $1,516 | $15 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,415 | $64 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 47 | $1,342 | $29 |
| External ekg recording for more than 48 hours up to 21 days | 36 | $1,149 | $28 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $1,016 | $20 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 53 | $1,007 | $18 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 36 | $1,006 | $25 |
| Ultrasonic guidance for blood vessel access | 60 | $871 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $372 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $360 | $24 |
| Ultrasound of heart, follow-up | 11 | $238 | $22 |
2018: 40 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $36,155 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 148 | $29,384 | $180 |
| Return visit (30+ min) | 202 | $29,344 | $94 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $15,222 | $491 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | $13,909 | $208 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 173 | $12,419 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $11,656 | $212 |
| Long return visit (40+ min) | 68 | $11,617 | $128 |
| Ultrasound of leg arteries or artery grafts | 32 | $8,983 | $272 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,519 | $418 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $7,333 | $319 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 18 | $5,191 | $288 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 560 | $4,865 | $7 |
| Ultrasound of both sides of head and neck blood flow | 23 | $4,721 | $205 |
| Short return visit (20+ min) | 68 | $4,640 | $61 |
| Ultrasound of heart with probe in esophagus, with report | 35 | $3,818 | $98 |
| New patient visit (45+ min) | 26 | $3,209 | $123 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 15 | $3,015 | $201 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $2,876 | $160 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,833 | $66 |
| Programming of dual lead pacemaker system | 26 | $2,407 | $53 |
| Ultrasound study of arm and leg arteries | 32 | $2,391 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 104 | $2,339 | $21 |
| New patient visit (60+ min) | 12 | $2,297 | $191 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 137 | $1,727 | $11 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,563 | $82 |
| Review by radiologist of arm or leg artery image | 14 | $1,387 | $87 |
| Ultrasound of heart, follow-up | 11 | $1,186 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 60 | $1,024 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 22 | $994 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $927 | $51 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $717 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 16 | $651 | $11 |
| Ultrasonic guidance for blood vessel access | 14 | $471 | $29 |
| Ultrasound of both sides of head and neck blood flow | 13 | $423 | $33 |
| Ultrasonic guidance for blood vessel access | 27 | $369 | $13 |
| Blood test, clotting time | 49 | $295 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $274 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $159 | $13 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17 | $100 | $0 |
2017: 33 services
| Return visit (30+ min) | 416 | $56,987 | $90 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 53 | $30,926 | $462 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 124 | $26,098 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $25,559 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $22,449 | $180 |
| Long return visit (40+ min) | 138 | $20,837 | $120 |
| Short return visit (20+ min) | 184 | $13,043 | $59 |
| Repair of left upper heart chamber with implant with review by radiologist | 16 | $11,087 | $693 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $9,021 | $56 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $7,642 | $402 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $6,764 | $307 |
| Ultrasound of heart with probe in esophagus, with report | 59 | $6,364 | $95 |
| New patient visit (45+ min) | 28 | $3,812 | $136 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 402 | $3,810 | $7 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 41 | $3,446 | $80 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $3,424 | $228 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 237 | $2,797 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $2,447 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,241 | $59 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,185 | $64 |
| Programming of dual lead pacemaker system | 22 | $2,118 | $56 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 24 | $1,972 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 96 | $1,473 | $14 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,257 | $114 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $958 | $32 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $882 | $80 |
| Ultrasonic guidance for blood vessel access | 42 | $624 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $580 | $53 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $484 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 15 | $342 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $341 | $15 |
| Blood test, clotting time | 21 | $206 | $5 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14 | $66 | $0 |
2016: 34 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 140 | $34,258 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 138 | $31,733 | $223 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 131 | $26,859 | $180 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 38 | $20,840 | $496 |
| Return visit (30+ min) | 111 | $18,026 | $93 |
| Short return visit (20+ min) | 166 | $17,233 | $64 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 74 | $15,682 | $209 |
| Replacement of aortic valve through the skin and femoral artery | 18 | $12,884 | $716 |
| Ultrasound of both sides of head and neck blood flow | 50 | $9,617 | $192 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $8,314 | $416 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 24 | $7,743 | $323 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $7,736 | $57 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 254 | $5,386 | $18 |
| Ultrasound of leg arteries or artery grafts | 21 | $4,119 | $196 |
| Ultrasound of heart with probe in esophagus, with report | 35 | $4,030 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 433 | $3,625 | $7 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 22 | $3,533 | $161 |
| Long return visit (40+ min) | 21 | $3,366 | $135 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $3,290 | $274 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 15 | $3,188 | $213 |
| New patient visit (45+ min) | 22 | $2,804 | $127 |
| New patient visit (30+ min) | 29 | $2,217 | $76 |
| Hospital observation care on day of discharge | 31 | $2,108 | $66 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 25 | $2,065 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 123 | $1,965 | $14 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,578 | $66 |
| Ultrasound study of arm and leg arteries | 21 | $1,519 | $72 |
| Review by radiologist of both arms or legs arteries image | 11 | $1,435 | $130 |
| Programming of dual lead pacemaker system | 19 | $1,359 | $52 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,336 | $121 |
| Blood test, clotting time | 110 | $903 | $5 |
| Ultrasonic guidance for blood vessel access | 45 | $640 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $294 | $27 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18 | $113 | $0 |
2015: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $32,061 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 130 | $24,547 | $178 |
| Short return visit (20+ min) | 192 | $17,782 | $68 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $12,728 | $509 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 51 | $11,428 | $208 |
| Return visit (30+ min) | 69 | $11,023 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 158 | $9,576 | $57 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $8,636 | $393 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 21 | $6,684 | $318 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,968 | $118 |
| Hospital discharge day management, 30 minutes or less | 46 | $3,021 | $66 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,482 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 132 | $2,353 | $16 |
| New patient visit (30+ min) | 19 | $1,807 | $95 |
| Long return visit (40+ min) | 11 | $1,738 | $134 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,733 | $83 |
| Ultrasonic guidance for blood vessel access | 71 | $1,037 | $13 |
| Short return visit | 11 | $498 | $42 |
| Radiological supervision and interpretation of ultrasound of blood vessel | 16 | $288 | $17 |
| Blood test, clotting time | 26 | $257 | $5 |
2013: 17 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,949 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 124 | $10,061 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $9,191 | $85 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | $6,414 | $267 |
| Long return visit (40+ min) | 80 | $6,090 | $74 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $4,279 | $357 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 362 | $3,586 | $7 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 12 | $2,777 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 47 | $2,397 | $48 |
| Return visit (30+ min) | 20 | $1,663 | $83 |
| Short return visit (20+ min) | 24 | $1,351 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 39 | $604 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 12 | $332 | $28 |
| Test to measure expiratory airflow and volume | 11 | $252 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $215 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $172 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $133 | $12 |
Medicaid work
$52,964 in 2024
Medicaid paid $52,964 for 1,354 billed services this clinician did in 2024, up to 126 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 398 | $19,228 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 141 | $9,844 |
| LOWER EXTREMITY STUDY | 93 | $8,502 |
| EXTREMITY STUDY | 72 | $6,697 |
| VASCULAR STUDY | 46 | $3,337 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 504 | $2,438 |
| Return visit (30+ min) | 47 | $1,834 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 41 | $870 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 12 | $214 |
| 2024 | 1,354 | 9 | 126 | $52,964 |
| 2023 | 1,915 | 10 | 106 | $53,651 |
| 2022 | 1,787 | 7 | 88 | $43,332 |
| 2021 | 934 | 6 | 85 | $20,735 |
| 2020 | 448 | 3 | 79 | $4,194 |
| 2019 | 124 | 1 | 51 | $412 |
| 2018 | 145 | 1 | 54 | $279 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 471 | $18,798 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 139 | $9,297 |
| Return visit (30+ min) | 107 | $6,500 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 225 | $5,693 |
| VASCULAR STUDY | 53 | $4,505 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 822 | $4,033 |
| LOWER EXTREMITY STUDY | 39 | $3,069 |
| EXTREMITY STUDY | 13 | $1,146 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 33 | $462 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 13 | $148 |
2022
| Short return visit (20+ min) | 372 | $15,996 |
| Return visit (30+ min) | 142 | $9,344 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 132 | $8,434 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,022 | $5,118 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 91 | $2,865 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $1,475 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $101 |
2021
| Short return visit (20+ min) | 185 | $7,658 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 630 | $7,127 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 56 | $3,833 |
| Return visit (30+ min) | 14 | $790 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $715 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 36 | $612 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 419 | $3,600 |
| Return visit (30+ min) | 16 | $345 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $250 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 124 | $412 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 145 | $279 |
Drugs they prescribed that Part D paid
$354,995
Pharmacies billed $354,995 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,412 generic and 299 brand-name prescriptions · $354,995 in drug cost · 60 antibiotic prescriptions to 45 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 137 | $186,514 | $1,361 |
| Entresto | 47 | $52,758 | $1,123 |
| Xarelto | 23 | $38,402 | $1,670 |
| Repatha Sureclick | 22 | $21,305 | $968 |
| Clopidogrel | 288 | $3,987 | $14 |
See all 39 drugs
| Eliquis | 137 | $186,514 | $1,361 |
| Entresto | 47 | $52,758 | $1,123 |
| Xarelto | 23 | $38,402 | $1,670 |
| Repatha Sureclick | 22 | $21,305 | $968 |
| Clopidogrel | 288 | $3,987 | $14 |
| Atorvastatin | 317 | $3,140 | $10 |
| Metoprolol | 201 | $2,869 | $14 |
| Flecainide Acetate | 62 | $2,251 | $36 |
| Rosuvastatin | 115 | $1,627 | $14 |
| Ezetimibe | 63 | $1,410 | $22 |
| Pantoprazole | 86 | $1,301 | $15 |
| Isosorbide Mononitrate Er | 58 | $1,262 | $22 |
| Carvedilol | 93 | $1,024 | $11 |
| Amlodipine Besylate | 105 | $1,005 | $10 |
| Lisinopril | 136 | $987 | $7 |
| Furosemide | 107 | $981 | $9 |
| Losartan | 81 | $925 | $11 |
| Metoprolol | 85 | $881 | $10 |
| Digoxin | 18 | $872 | $48 |
| Potassium Chloride | 51 | $704 | $14 |
| Diltiazem 24hr Er (Cd) | 21 | $671 | $32 |
| Hydrochlorothiazide | 57 | $634 | $11 |
| Valsartan | 11 | $448 | $41 |
| Olmesartan Medoxomil | 16 | $439 | $27 |
| Bumetanide | 17 | $412 | $24 |
| Amiodarone | 16 | $373 | $23 |
| Hydralazine | 26 | $327 | $13 |
| Cephalexin | 31 | $296 | $10 |
| Nitroglycerin | 23 | $268 | $12 |
| Atenolol | 34 | $265 | $8 |
| Losartan-Hydrochlorothiazide | 16 | $252 | $16 |
| Benazepril | 16 | $243 | $15 |
| Levothyroxine | 14 | $206 | $15 |
| Gabapentin | 14 | $193 | $14 |
| Warfarin | 17 | $174 | $10 |
| Spironolactone | 15 | $173 | $12 |
| Clonidine | 25 | $155 | $6 |
| Pravastatin | 13 | $135 | $10 |
| Doxycycline Hyclate | 15 | $97 | $6 |
Year by year
| 2024 | 2,711 | 545 | None | 11% | $354,995 |
| 2023 | 2,544 | 475 | None | 11% | $341,897 |
| 2022 | 2,754 | 406 | None | 13% | $313,705 |
| 2021 | 2,387 | 363 | None | 15% | $261,223 |
| 2020 | 2,366 | 306 | 1% (13) | 17% | $296,584 |
| 2019 | 1,669 | 253 | 1% (17) | 14% | $148,764 |
| 2018 | 1,262 | 208 | None | 10% | $74,192 |
| 2017 | 1,159 | 218 | None | 14% | $62,808 |
| 2016 | 779 | 148 | None | None | $45,466 |
| 2015 | 384 | 91 | None | None | $13,434 |
| 2014 | 37 | 19 | 0% (0) | None | $2,214 |
| 2013 | 1,126 | 176 | None | 23% | $65,898 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Eliquis | 137 | $172,628 | $1,260 |
| Entresto | 41 | $46,681 | $1,139 |
| Xarelto | 26 | $41,956 | $1,614 |
| Atorvastatin | 309 | $4,513 | $15 |
| Clopidogrel | 221 | $4,333 | $20 |
| Metoprolol | 176 | $3,674 | $21 |
| Rosuvastatin | 107 | $3,487 | $33 |
| Flecainide Acetate | 64 | $2,994 | $47 |
| Ezetimibe | 55 | $2,660 | $48 |
| Losartan | 89 | $2,007 | $23 |
| Isosorbide Mononitrate Er | 55 | $1,749 | $32 |
| Pantoprazole | 82 | $1,630 | $20 |
| Diltiazem 24hr Er (Cd) | 27 | $1,494 | $55 |
| Carvedilol | 84 | $1,371 | $16 |
| Amlodipine Besylate | 120 | $1,257 | $10 |
| Lisinopril | 113 | $1,224 | $11 |
| Potassium Chloride | 45 | $1,192 | $26 |
| Furosemide | 111 | $1,030 | $9 |
| Warfarin | 36 | $1,002 | $28 |
| Metoprolol | 74 | $994 | $13 |
| Amiodarone | 26 | $964 | $37 |
| Nitroglycerin | 24 | $857 | $36 |
| Diltiazem 24hr Er | 13 | $629 | $48 |
| Hydrochlorothiazide | 65 | $575 | $9 |
| Valsartan | 11 | $511 | $46 |
| Digoxin | 16 | $430 | $27 |
| Spironolactone | 21 | $387 | $18 |
| Cephalexin | 31 | $363 | $12 |
| Atenolol | 30 | $336 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $304 | $25 |
| Hydralazine | 13 | $214 | $16 |
| Clonidine | 27 | $175 | $6 |
| Simvastatin | 14 | $138 | $10 |
2022: 36 drugs
| Eliquis | 114 | $124,726 | $1,094 |
| Xarelto | 49 | $45,839 | $935 |
| Entresto | 27 | $29,047 | $1,076 |
| Repatha Sureclick | 18 | $22,936 | $1,274 |
| Rosuvastatin | 103 | $4,785 | $46 |
| Atorvastatin | 356 | $4,364 | $12 |
| Metoprolol | 194 | $3,570 | $18 |
| Clopidogrel | 240 | $3,176 | $13 |
| Flecainide Acetate | 49 | $2,361 | $48 |
| Isosorbide Mononitrate Er | 44 | $2,087 | $47 |
| Ezetimibe | 41 | $1,981 | $48 |
| Losartan | 113 | $1,894 | $17 |
| Potassium Chloride | 75 | $1,727 | $23 |
| Amiodarone | 18 | $1,395 | $77 |
| Carvedilol | 98 | $1,265 | $13 |
| Pantoprazole | 58 | $1,258 | $22 |
| Furosemide | 145 | $1,244 | $9 |
| Amlodipine Besylate | 119 | $1,028 | $9 |
| Lisinopril | 123 | $1,026 | $8 |
| Metoprolol | 97 | $967 | $10 |
| Digoxin | 21 | $964 | $46 |
| Warfarin | 34 | $853 | $25 |
| Diltiazem 24hr Er (Cd) | 13 | $838 | $64 |
| Diltiazem 24hr Er | 12 | $733 | $61 |
| Clonidine | 36 | $710 | $20 |
| Nitroglycerin | 34 | $676 | $20 |
| Valsartan | 15 | $618 | $41 |
| Enalapril Maleate | 14 | $473 | $34 |
| Atenolol | 36 | $426 | $12 |
| Losartan-Hydrochlorothiazide | 16 | $401 | $25 |
| Hydrochlorothiazide | 52 | $389 | $7 |
| Simvastatin | 28 | $337 | $12 |
| Gabapentin | 17 | $291 | $17 |
| Spironolactone | 23 | $234 | $10 |
| Levothyroxine | 19 | $182 | $10 |
| Cephalexin | 28 | $155 | $6 |
2021: 34 drugs
| Eliquis | 112 | $107,478 | $960 |
| Xarelto | 55 | $60,795 | $1,105 |
| Metoprolol | 141 | $4,055 | $29 |
| Flecainide Acetate | 53 | $3,956 | $75 |
| Atorvastatin | 228 | $3,135 | $14 |
| Rosuvastatin | 75 | $2,956 | $39 |
| Clopidogrel | 182 | $2,458 | $14 |
| Isosorbide Mononitrate Er | 56 | $2,335 | $42 |
| Ezetimibe | 46 | $1,980 | $43 |
| Potassium Chloride | 82 | $1,979 | $24 |
| Losartan | 101 | $1,949 | $19 |
| Diltiazem 24hr Er (Cd) | 14 | $1,702 | $122 |
| Metoprolol | 92 | $1,283 | $14 |
| Amiodarone | 25 | $1,258 | $50 |
| Furosemide | 154 | $1,139 | $7 |
| Amlodipine Besylate | 121 | $1,040 | $9 |
| Pantoprazole | 37 | $1,014 | $27 |
| Lisinopril | 115 | $949 | $8 |
| Carvedilol | 75 | $828 | $11 |
| Warfarin | 39 | $778 | $20 |
| Digoxin | 29 | $621 | $21 |
| Enalapril Maleate | 13 | $601 | $46 |
| Bumetanide | 13 | $546 | $42 |
| Clonidine | 24 | $434 | $18 |
| Nitroglycerin | 21 | $432 | $21 |
| Hydralazine | 14 | $429 | $31 |
| Atenolol | 37 | $422 | $11 |
| Hydrochlorothiazide | 46 | $368 | $8 |
| Pravastatin | 14 | $358 | $26 |
| Simvastatin | 27 | $276 | $10 |
| Losartan-Hydrochlorothiazide | 18 | $252 | $14 |
| Spironolactone | 13 | $176 | $14 |
| Cephalexin | 18 | $113 | $6 |
| Amoxicillin | 13 | $23 | $2 |
2020: 37 drugs
| Eliquis | 115 | $111,116 | $966 |
| Xarelto | 99 | $93,530 | $945 |
| Praluent | 12 | $14,204 | $1,184 |
| Bystolic | 11 | $3,974 | $361 |
| Flecainide Acetate | 47 | $3,826 | $81 |
| Atorvastatin | 225 | $3,665 | $16 |
| Metoprolol | 120 | $3,347 | $28 |
| Potassium Chloride | 90 | $2,778 | $31 |
| Ranolazine Er | 21 | $2,513 | $120 |
| Rosuvastatin | 68 | $2,330 | $34 |
| Amiodarone | 36 | $2,235 | $62 |
| Clopidogrel | 124 | $2,123 | $17 |
| Isosorbide Mononitrate Er | 86 | $2,112 | $25 |
| Ezetimibe | 29 | $1,847 | $64 |
| Losartan | 79 | $1,398 | $18 |
| Digoxin | 41 | $1,118 | $27 |
| Bumetanide | 16 | $1,022 | $64 |
| Warfarin | 45 | $854 | $19 |
| Metoprolol | 105 | $853 | $8 |
| Amlodipine Besylate | 108 | $830 | $8 |
| Enalapril Maleate | 13 | $801 | $62 |
| Losartan-Hydrochlorothiazide | 21 | $787 | $37 |
| Furosemide | 128 | $780 | $6 |
| Carvedilol | 68 | $772 | $11 |
| Lisinopril | 86 | $557 | $6 |
| Clonidine | 37 | $490 | $13 |
| Pantoprazole | 39 | $464 | $12 |
| Hydralazine | 19 | $452 | $24 |
| Nitroglycerin | 26 | $434 | $17 |
| Atenolol | 39 | $392 | $10 |
| Levothyroxine | 18 | $386 | $21 |
| Hydrochlorothiazide | 41 | $303 | $7 |
| Prasugrel | 13 | $301 | $23 |
| Simvastatin | 34 | $298 | $9 |
| Olmesartan Medoxomil | 12 | $187 | $16 |
| Spironolactone | 16 | $132 | $8 |
| Cephalexin | 12 | $57 | $5 |
2019: 34 drugs
| Xarelto | 64 | $51,442 | $804 |
| Eliquis | 46 | $36,471 | $793 |
| Atorvastatin | 185 | $3,202 | $17 |
| Flecainide Acetate | 39 | $2,738 | $70 |
| Metoprolol | 81 | $2,351 | $29 |
| Potassium Chloride | 49 | $2,101 | $43 |
| Clopidogrel | 99 | $1,710 | $17 |
| Rosuvastatin | 33 | $1,548 | $47 |
| Ezetimibe | 23 | $1,444 | $63 |
| Amiodarone | 28 | $1,416 | $51 |
| Digoxin | 32 | $1,357 | $42 |
| Clonidine | 13 | $1,341 | $103 |
| Isosorbide Mononitrate Er | 76 | $1,279 | $17 |
| Enalapril Maleate | 11 | $772 | $70 |
| Hydralazine | 23 | $726 | $32 |
| Losartan | 50 | $714 | $14 |
| Lisinopril | 73 | $698 | $10 |
| Carvedilol | 65 | $672 | $10 |
| Nitroglycerin | 30 | $665 | $22 |
| Metoprolol | 59 | $660 | $11 |
| Warfarin | 24 | $606 | $25 |
| Pantoprazole | 30 | $507 | $17 |
| Furosemide | 67 | $478 | $7 |
| Amlodipine Besylate | 48 | $438 | $9 |
| Clonidine | 23 | $416 | $18 |
| Atenolol | 19 | $347 | $18 |
| Fludrocortisone Acetate | 11 | $281 | $26 |
| Levothyroxine | 14 | $246 | $18 |
| Diltiazem 24hr Er (Cd) | 15 | $244 | $16 |
| Simvastatin | 17 | $165 | $10 |
| Losartan-Hydrochlorothiazide | 16 | $155 | $10 |
| Hydrocodone-Acetaminophen | 17 | $132 | $8 |
| Hydrochlorothiazide | 25 | $111 | $4 |
| Spironolactone | 15 | $75 | $5 |
2018: 26 drugs
| Eliquis | 41 | $29,795 | $727 |
| Xarelto | 20 | $15,380 | $769 |
| Atorvastatin | 126 | $1,929 | $15 |
| Clopidogrel | 190 | $1,905 | $10 |
| Metoprolol | 57 | $1,576 | $28 |
| Flecainide Acetate | 25 | $1,528 | $61 |
| Isosorbide Mononitrate Er | 91 | $1,486 | $16 |
| Amiodarone | 17 | $894 | $53 |
| Digoxin | 19 | $747 | $39 |
| Potassium Chloride | 23 | $702 | $31 |
| Hydralazine | 19 | $600 | $32 |
| Rosuvastatin | 14 | $496 | $35 |
| Warfarin | 34 | $458 | $13 |
| Metoprolol | 64 | $433 | $7 |
| Lisinopril | 69 | $380 | $6 |
| Furosemide | 72 | $349 | $5 |
| Nitroglycerin | 15 | $348 | $23 |
| Torsemide | 12 | $246 | $21 |
| Losartan | 21 | $229 | $11 |
| Carvedilol | 34 | $224 | $7 |
| Bisoprolol | 11 | $156 | $14 |
| Pantoprazole | 20 | $156 | $8 |
| Amlodipine Besylate | 23 | $155 | $7 |
| Diltiazem 24hr Er (Cd) | 13 | $153 | $12 |
| Clonidine | 15 | $115 | $8 |
| Simvastatin | 14 | $44 | $3 |
2017: 20 drugs
| Eliquis | 38 | $22,986 | $605 |
| Ezetimibe | 11 | $2,220 | $202 |
| Clopidogrel | 211 | $2,194 | $10 |
| Atorvastatin | 129 | $1,585 | $12 |
| Amiodarone | 22 | $1,330 | $60 |
| Metoprolol | 45 | $1,299 | $29 |
| Isosorbide Mononitrate Er | 84 | $1,244 | $15 |
| Warfarin | 52 | $665 | $13 |
| Potassium Chloride | 33 | $622 | $19 |
| Carvedilol | 57 | $427 | $7 |
| Nitroglycerin | 12 | $410 | $34 |
| Metoprolol | 56 | $390 | $7 |
| Digoxin | 11 | $380 | $35 |
| Furosemide | 71 | $326 | $5 |
| Lisinopril | 40 | $248 | $6 |
| Pantoprazole | 18 | $235 | $13 |
| Diltiazem 24hr Er | 14 | $188 | $13 |
| Losartan | 17 | $185 | $11 |
| Amlodipine Besylate | 21 | $135 | $6 |
| Atenolol | 17 | $52 | $3 |
2016: 14 drugs
| Eliquis | 27 | $12,056 | $447 |
| Xarelto | 11 | $5,198 | $473 |
| Clopidogrel | 94 | $1,150 | $12 |
| Metoprolol | 34 | $1,149 | $34 |
| Atorvastatin | 60 | $1,037 | $17 |
| Amiodarone | 22 | $894 | $41 |
| Isosorbide Mononitrate Er | 59 | $888 | $15 |
| Carvedilol | 63 | $423 | $7 |
| Furosemide | 77 | $416 | $5 |
| Losartan | 25 | $329 | $13 |
| Amlodipine Besylate | 34 | $222 | $7 |
| Metoprolol | 35 | $206 | $6 |
| Warfarin | 17 | $142 | $8 |
| Lisinopril | 27 | $85 | $3 |
2015: 11 drugs
| Eliquis | 11 | $3,513 | $319 |
| Metoprolol | 20 | $1,004 | $50 |
| Amiodarone | 12 | $643 | $54 |
| Clopidogrel | 52 | $549 | $11 |
| Metoprolol | 40 | $319 | $8 |
| Isosorbide Mononitrate Er | 23 | $248 | $11 |
| Atorvastatin | 19 | $187 | $10 |
| Carvedilol | 41 | $171 | $4 |
| Furosemide | 18 | $93 | $5 |
| Amlodipine Besylate | 12 | $62 | $5 |
| Lisinopril | 12 | $57 | $5 |
2013: 20 drugs
| Crestor | 57 | $11,887 | $209 |
| Pradaxa | 23 | $6,136 | $267 |
| Niaspan | 25 | $5,495 | $220 |
| Zetia | 12 | $4,245 | $354 |
| Fenofibrate | 31 | $2,746 | $89 |
| Clopidogrel | 91 | $2,440 | $27 |
| Metoprolol | 47 | $2,280 | $49 |
| Atorvastatin | 44 | $1,319 | $30 |
| Valsartan-Hydrochlorothiazide | 17 | $1,233 | $73 |
| Carvedilol | 104 | $1,213 | $12 |
| Isosorbide Mononitrate Er | 54 | $1,096 | $20 |
| Metoprolol | 71 | $857 | $12 |
| Simvastatin | 89 | $782 | $9 |
| Amiodarone | 28 | $539 | $19 |
| Lisinopril | 56 | $475 | $8 |
| Warfarin | 30 | $366 | $12 |
| Hydrochlorothiazide | 32 | $310 | $10 |
| Amlodipine Besylate | 34 | $269 | $8 |
| Furosemide | 35 | $190 | $5 |
| Digox | 20 | $179 | $9 |
Money from drug and device companies
$1,940 in 2025
| 2025 | 4 | 17 | None | $1,940 |
| 2024 | 5 | 5 | None | $128 |
| 2023 | 8 | 22 | None | $1,783 |
| 2022 | 11 | 49 | None | $1,106 |
| 2021 | 8 | 25 | None | $519 |
| 2020 | 6 | 15 | None | $413 |
| 2019 | 7 | 18 | $3,500 | $3,954 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Triclip | $1,549 | 12 payments
|
| Abiomed | None | $294 | 2 payments
|
| Smith+Nephew | Grafix | $73 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $24 | 1 payment
|
See all 17 published payments
| Abbott Laboratories | Meals · 2025-11-26 | Triclip | $31 |
| Abbott Laboratories | Meals · 2025-11-26 | Triclip | $72 |
| Abbott Laboratories | Travel · 2025-11-26 | Triclip | $68 |
| Abbott Laboratories | Travel · 2025-09-11 | Triclip | $865 |
| Abbott Laboratories | Travel · 2025-09-11 | Triclip | $33 |
| Abbott Laboratories | Travel · 2025-09-11 | Triclip | $37 |
| Abbott Laboratories | Travel · 2025-09-11 | Triclip | $9 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $28 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $28 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $28 |
| Abbott Laboratories | Meals · 2025-09-08 | Triclip | $3 |
| Abbott Laboratories | Travel · 2025-09-08 | Triclip | $347 |
| Smith+Nephew | Meals · 2025-08-25 | Grafix | $49 |
| Smith+Nephew | Meals · 2025-06-28 | Collagenase Santyl | $23 |
| Baxter Healthcare | Meals · 2025-06-06 | Hillrom - Carnation Ambulatory Monitor | $24 |
| Abiomed | Meals · 2025-06-04 | None | $147 |
| Abiomed | Meals · 2025-04-04 | None | $147 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $128
| Sirtex Medical | Sir-Spheres Microspheres | $38 | 1 payment
|
| Organogenesis | None | $28 | 1 payment
|
| Abbott Laboratories | Assurity | $25 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $22 | 1 payment
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $16 | 1 payment
|
2023: $1,783
| Medical Device Business Services | Carto 3 | $1,194 | 9 payments
|
| Abbott Laboratories | Diamondback Coronary | $145 | 3 payments
|
| Biosense Webster | None | $139 | 1 payment
|
| Endologix | None | $94 | 1 payment
|
| Organogenesis | Puraply | $89 | 4 payments
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $57 | 2 payments
|
| Bard Peripheral Vascular | Venclose Maven Catheter | $52 | 1 payment
|
| Medtronic | Azure Xt Dr Mri Surescan | $13 | 1 payment
|
2022: $1,106
| Abbott Laboratories | Cardiomems | $248 | 10 payments
|
| Organogenesis | Puraply | $219 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $165 | 9 payments
|
| Integra LifeSciences | Integra | $145 | 1 payment
|
| Medtronic | Azure Xt Dr Mri Surescan | $126 | 15 payments
|
| Amgen | Repatha | $104 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $24 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $22 | 1 payment
|
| Pfizer | Eliquis | $19 | 1 payment
|
| Boston Scientific | General - Atherectomy | $17 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $16 | 1 payment
|
2021: $519
| Janssen Pharmaceuticals | Xarelto | $142 | 14 payments
|
| Organogenesis | Puraply | $136 | 1 payment
|
| Esperion Therapeutics | Nexletol | $53 | 2 payments
|
| Amgen | Repatha | $47 | 2 payments
|
| Abbott Laboratories | Merlin Connectivity and Remote | $47 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $43 | 2 payments
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $26 | 1 payment
|
| Amarin Pharma | Vascepa | $23 | 1 payment
|
2020: $413
| Abbott Laboratories | Mitra Clip System | $168 | 4 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $123 | 5 payments
|
| Astellas Pharma US | Lexiscan | $45 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $35 | 2 payments
|
| Esperion Therapeutics | Nexletol | $22 | 1 payment
|
| Amarin Pharma | Vascepa | $20 | 1 payment
|
2019: $3,954
| Terumo Medical | None | $3,500 | 2 payments
|
| Abbott Laboratories | Confirm Rx | $210 | 5 payments
|
| Medtronic Vascular | Corevalve Evolut | $113 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $57 | 3 payments
|
| Amgen | Repatha | $30 | 1 payment
|
| Biotronik | None | $23 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Endologix LLC · Detour II Study · 2023 | Their institution | $32,150 |
| Endologix LLC · Detour II Study · 2022 | Their institution | $14,560 |
| Medtronic Vascular, Inc. · Tavr Low Risk · 2019 | Their institution | $13,901 |
| Endologix LLC · Detour II Study · 2024 | Their institution | $9,790 |
| Medtronic, Inc. · Tavr Low Risk · 2021 | Their institution | $4,809 |
| Medtronic, Inc. · Tavr Low Risk · 2022 | Their institution | $3,670 |
| Medtronic Vascular, Inc. · Tavr Low Risk · 2020 | Their institution | $3,513 |
| Medtronic, Inc. · Corevalve Surtavi · 2021 | Their institution | $3,278 |
| Medtronic Vascular, Inc. · Tavr Low Risk Cas · 2019 | Their institution | $3,246 |
| Medtronic, Inc. · Tavr Low Risk · 2025 | Their institution | $3,144 |
| Endologix LLC · Detour II Study · 2021 | Their institution | $3,060 |
| Medtronic, Inc. · Tavr Low Risk · 2023 | Their institution | $1,619 |
| Medtronic, Inc. · Tavr Low Risk · 2024 | Their institution | $1,477 |
| Medtronic, Inc. · Tavr Low Risk Cas · 2021 | Their institution | $1,170 |
| Medtronic, Inc. · Corevalve Surtavi · 2024 | Their institution | $875 |
| Medtronic Vascular, Inc. · Tavr Low Risk Cas · 2020 | Their institution | $734 |
| Medtronic, Inc. · Corevalve Surtavi · 2022 | Their institution | $685 |
| Medtronic, Inc. · Corevalve Surtavi · 2023 | Their institution | $266 |
| Medtronic, Inc. · Corevalve Surtavi · 2025 | Their institution | $149 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1336198878
- Licence
- CA C55862California C55862: Current · expires 2026-12-31
- Trained
- Northeastern Ohio University College of Medicine, 1998
- Group
- Golden State Heart and Vascular Associates · Community Hospital of the Monterey Peninsula
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 1850 El Camino Real Ste 200, Burlingame, CA, 94010
- NPI first listed
- 2006-05-10
- NPI last updated
- 2023-03-07
- NPI record certified
- 2022-01-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 625 Lincoln Ave, San Jose, CA, 95126